IP Library › Patent Application 10984030
Patent Application
App. No. 10/984,030

Method for nucleic acid preparation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/984,030
Abstract

Concentration of oligonucleotides in salt solutions is accomplished by loading a solution of the oligonucleotide dissolved in aqueous sodium chloride or other salt solution onto a reverse-phase poly(styrene-divinylbene) liquid chromatography (LC) column. The column bearing oligonucleotide is then washed with water to low conductivity and eluted with an organic eluent such as ethanol, thus effecting a combination desalting concentration procedure in one step, thus this procedure has utility in the desalting and concentration of oligonucleotides that have been purified and/or treated by anion exchange chromatography. In situ cationic exchange of the associated cation of the oligonucleotide can also be incorporated into the procedure of the new invention.

Claims (28)

1 . A method of desalting and concentrating a nucleic acid within a sample, said method comprising the steps of:

contacting the sample with a binding medium comprising a strongly hydrophobic base matrix; and

eluting the nucleic acid with an aqueous organic solvent.

2 . The method of claim 1 , wherein the binding medium is comprised of poly(styrene-divinylbenzene).

3 . The method of claim 1 , wherein the binding medium is a column comprised of particles having a diameter of about 1 micron to about 250 microns.

4 . The method of claim 3 , wherein the binding medium is a column comprised of particles having a diameter of about 50 to about 75 microns.

5 . The method of claim 1 , further comprising the step of:

rinsing the binding medium with an unbuffered aqueous solution prior to elution.

6 . The method of claim 5 , wherein the unbuffered aqueous solution is water.

7 . The method of claim 5 , wherein an effluent conductivity following rinsing is at or below 100 microSiemens/cm.

8 . The method of claim 7 , wherein the effluent conductivity following rinsing is at or below 25 microSiemens/cm.

9 . The method of claim 1 , wherein the nucleic acid has been modified with a compound selected from the group consisting of: biotin, fluorescein and related dyes, spacers, thiol modifiers, amino modifiers, carboxylate modifiers, or any combination of these.

10 . The method of claim 1 , wherein the nucleic acid is selected from the group consisting of: a DNA phosphodiester, RNA phosphodiester, phosphorothioate, methylphosphonate, 2′-methyl RNA, 2′-O-alkyl RNA, 2′-O-methyl DNA, 2′-O-alkyl DNA and chimeras containing such structures.

11 . The method of claim 1 , wherein the nucleic acid comprises nucleotide bases selected from the group consisting of: 5-methylcytidine, inosine, halogenated uridines, etheno-bases, dideoxynucleosides, and inverted bases.

12 . The method of claim 1 , wherein the nucleic acid is comprised of inverted 3′-5′ linkages.

13 . The method of claim 1 , wherein the nucleic acid is comprised of 5′-2′ linkages.

14 . The method of claim 1 , wherein the nucleic acid is an oligonucleotide comprised of about 1 to about 100 nucleotides.

15 . The method of claim 1 , wherein the sample is the product of strong anion exchange chromatography.

16 . The method of claim 1 , wherein the sample is the product of weak anion exchange chromatography.

17 . The method of claim 1 , wherein the sample is derived from a biological source material.

18 . The method of claim 1 , wherein the aqueous organic solvent is selected from the group consisting of acetonitrile, n-propanol, isopropanol, or methanol.

19 . The method of claim 1 wherein the aqueous organic solvent is aqueous ethanol.

20 . A method of exchanging a cation associated with a nucleic acid in a sample, comprising the steps of:

contacting a nucleic acid associated with a first cation with a binding medium comprising a strongly hydrophobic base matrix;

rinsing the nucleic acid bound to the binding medium with an unbuffered aqueous solution prior to elution;

contacting the bound nucleic acid with a solution comprised of a second cation; and

eluting the nucleic acid associated with the second cation from the binding medium;

wherein the second cation effectively displaces the first cation in the effluent sample.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2009
From: LAKEWOOD-AMEDEX, INC.
To: OLIGOS, ETC., INC.
Reel/Frame 023450/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2009
From: LAKEWOOD-AMEDEX, INC.
To: OLIGOS, ETC., INC.
Reel/Frame 023389/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2009
From: OLIGOS ETC., INC.
To: LAKEWOOD-AMEDEX, INC.
Reel/Frame 022162/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2005
From: DALE, RODERIC M.K.; GATTON, STEVEN L.
To: OLIGOS ETC., INC.
Reel/Frame 016325/0023 →